Clinical trial
A Pilot Study of the Effects of Botulinum Toxin in the Treatment of Provoked Vestibulodynia
NCT02858219 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Besancon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study of the Effects of Botulinum Toxin in the Treatment of Provoked Vestibulodynia
- Lead sponsor
- Centre Hospitalier Universitaire de Besancon
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 4, 2010
- Completion date
- February 11, 2019
- Enrollment
- 60 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
vestibulodynia